https://www.selleckchem.com/pr....oducts/incb28060.htm
001) and the prednisolone discontinuation rate was higher (80.0% vs. 28.3% vs. 18.8%, p less then 0.0001) in the tocilizumab group than in the prednisolone and methotrexate groups. This study suggested that tocilizumab has a steroid-sparing effect in PMR. Tocilizumab can be an option in the management of PMR. Future studies are warranted to confirm our findings.Background and Objectives The daily lifestyle management of diabetes requires accurate predictions of the blood glucose level between meals. The objective of this study was to
Like
Comment
Share
